Thomas Conrad

550 total citations · 1 hit paper
9 papers, 153 citations indexed

About

Thomas Conrad is a scholar working on Epidemiology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Thomas Conrad has authored 9 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Infectious Diseases and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Thomas Conrad's work include Pneumonia and Respiratory Infections (3 papers), Respiratory viral infections research (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Thomas Conrad is often cited by papers focused on Pneumonia and Respiratory Infections (3 papers), Respiratory viral infections research (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Thomas Conrad collaborates with scholars based in United States, United Kingdom and Malawi. Thomas Conrad's co-authors include Melinda M. Pettigrew, Derek J. Williams, Emmanuel B. Walter, Howard Lee, W. Charles Huskins, Judith M. Martin, Vance G. Fowler, Theoklis E. Zaoutis, Scott Evans and Marina S. Lee and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Thomas Conrad

8 papers receiving 146 citations

Hit Papers

Short- vs Standard-Course Outpatient Antibiotic Therapy f... 2022 2026 2023 2024 2022 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Conrad United States 4 60 38 30 24 22 9 153
Kathryn Moffett United States 8 52 0.9× 9 0.2× 29 1.0× 15 0.6× 27 1.2× 24 183
Matthew Laundy United Kingdom 6 77 1.3× 25 0.7× 50 1.7× 3 0.1× 64 2.9× 6 204
Nicholas Price United Kingdom 5 63 1.1× 11 0.3× 10 0.3× 34 1.4× 17 0.8× 7 191
Polycarp Mogeni United Kingdom 7 27 0.5× 21 0.6× 108 3.6× 11 0.5× 22 1.0× 13 166
Emily Welch United States 4 124 2.1× 12 0.3× 19 0.6× 11 0.5× 31 1.4× 8 287
Philip Wikman‐Jorgensen Spain 10 48 0.8× 34 0.9× 12 0.4× 8 0.3× 95 4.3× 29 236
Beza Eshetu Ethiopia 6 18 0.3× 14 0.4× 30 1.0× 4 0.2× 19 0.9× 16 86
Fatou Berthé United States 9 19 0.3× 52 1.4× 32 1.1× 80 3.3× 28 1.3× 20 247
Nurhayat Yakut Türkiye 9 87 1.4× 25 0.7× 38 1.3× 2 0.1× 76 3.5× 41 229
Maimuna Ahmed Tanzania 5 42 0.7× 36 0.9× 28 0.9× 7 0.3× 18 0.8× 10 128

Countries citing papers authored by Thomas Conrad

Since Specialization
Citations

This map shows the geographic impact of Thomas Conrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Conrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Conrad more than expected).

Fields of papers citing papers by Thomas Conrad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Conrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Conrad. The network helps show where Thomas Conrad may publish in the future.

Co-authorship network of co-authors of Thomas Conrad

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Conrad. A scholar is included among the top collaborators of Thomas Conrad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Conrad. Thomas Conrad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zhang, Cindy, Thomas Conrad, David Hermann, et al.. (2024). Clofazimine pharmacokinetics in HIV‐infected adults with diarrhea: Implications of diarrheal disease on absorption of orally administered therapeutics. CPT Pharmacometrics & Systems Pharmacology. 13(3). 410–423. 2 indexed citations
2.
Nyirenda, James, Marc Henrion, Jacob Phulusa, et al.. (2023). Examination of ELISA against PCR for assessing treatment efficacy against Cryptosporidium in a clinical trial context. PLoS ONE. 18(9). e0289929–e0289929. 2 indexed citations
3.
Balevic, Stephen J., Shruti M. Raja, Gregory A. Deye, et al.. (2022). Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions. Infectious Diseases and Therapy. 11(2). 841–852. 4 indexed citations
4.
Williams, Derek J., C. Buddy Creech, Emmanuel B. Walter, et al.. (2022). Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children. JAMA Pediatrics. 176(3). 253–253. 80 indexed citations breakdown →
5.
Sivapalasingam, Sumathi, George A. Saviolakis, Kirsten Kulcsar, et al.. (2021). Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus. The Journal of Infectious Diseases. 225(10). 1765–1772. 3 indexed citations
6.
Williams, Derek J., C. Buddy Creech, Emmanuel B. Walter, et al.. (2020). 175. Randomized Double-blind Controlled Trial of Short vs. Standard Course Outpatient Therapy of Community Acquired Pneumonia in Children (SCOUT-CAP). Open Forum Infectious Diseases. 7(Supplement_1). S216–S216.
7.
Lé, Lan Anh, Thomas Conrad, Akiko Sakai, et al.. (2020). Nutritional conditions and oxygen concentration affect spontaneous occurrence of homologous recombination events but not spontaneous mutagenesis in <i>Escherichia coli</i>. Genes & Genetic Systems. 95(2). 85–93. 1 indexed citations
8.
Cohen, Morris J., Kimford J. Meador, Ryan May, et al.. (2019). Fetal antiepileptic drug exposure and learning and memory functioning at 6 years of age: The NEAD prospective observational study. Epilepsy & Behavior. 92. 154–164. 29 indexed citations
9.
An, Guohua, Daryl J. Murry, Kiran Gajurel, et al.. (2019). Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study. Antimicrobial Agents and Chemotherapy. 63(4). 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026